Regulation of MSC and macrophage functions in bone healing by peptide LL-37-loaded silk fibroin nanoparticles on a titanium surface.
He. Ye Y; Yang. Xin X; Yuan. Zhang Z; Shen. Xinkun X; Xu. Kun K; Lin. Chuanchuan C; Tao. Bailong B; Li. Ke K; Chen. Maowen M; Hu. Yan Y; Luo. Zhong Z; Xia. Zengzilu Z; Cai. Kaiyong K
Key Findings
- LL‑37‑loaded silk fibroin nanoparticles improve the survival, recruitment, and signaling of mesenchymal stem cells (MSCs) and macrophages on titanium surfaces.
- The modified implant promotes a beneficial switch in macrophage phenotype and enhances MSC differentiation, resulting in more bone formation after 28 days.
- In vivo experiments showed increased recruitment of MSCs and macrophages to the injury site and a positively regulated inflammatory response.
Practical Outcomes
- For most biohackers, this research isn’t directly usable because it involves specialized implant coatings, not a supplement or protocol you can take at home. However, it highlights that LL‑37 can modulate immune and stem‑cell activity, which may become relevant if future products (e.g., wound‑healing patches or bone‑regeneration kits) incorporate this peptide.
Summary
Scientists put a tiny peptide called LL‑37 into silk‑based particles and stuck them onto titanium implants. This coating helped stem cells and immune cells work together better, leading to faster bone healing around the implant in animal tests.
Abstract
Titanium-based materials have been long regarded as effective bone implants for clinical use, yet the corresponding osteointegration ability needs to be optimized. This challenge can be overcome by fabricating titanium (Ti) materials with physiological functions. In this study, peptide LL-37-loaded silk fibroin nanoparticles (SFNPs) were immobilized on a titanium surface to facilitate osteointegration by regulating the physiological functions of mesenchymal stem cells (MSCs) and macrophages. According to our results, the cell viability, recruitment and paracrine responses of MSCs and macrophages were improved by the modified Ti samples. MSC differentiation was promoted by the macrophages incubated on the modified Ti samples, and the phenotype switch of macrophages was also modulated by the MSCs incubated on the modified Ti samples. In vivo studies proved that the modified Ti implant induced MSC and macrophage recruitments to injury sites and the inflammatory response was positively regulated. Moreover, better bone formation was achieved around the modified Ti implant 28 days after surgery. This suggested that the immobilization of peptide LL-37-loaded SFNPs on a titanium surface improves osteointegration via the regulation of physiological functions of MSCs and macrophages.
Study Information
pubmed
2019
2019-11-19T00:00:00.000Z
10.1039/c9bm01158g
23
48